CNBC's Jim Cramer is eyeing the long-awaited interest rate decision from the Federal Reserve and earnings from restaurant chain companies Darden and Cracker Barrel.
Investors are broadly expecting the central bank to issue a rate cut but are unsure whether it will be by 25 or 50 basis points. Cramer said he's betting on the former. "There's simply no reason for the Fed to take that chance when it can simply hit us with a series of thoughtful 25 basis point cuts that neither reignite inflation nor cause panic," he said.on Friday guided investors through next week's top Wall Street action, highlighting a long-awaited interest rate decision from the Federal Reserve and earnings from restaurant chain companies Darden and Cracker Barrel.
"There's simply no reason for the Fed to take that chance when it can simply hit us with a series of thoughtful 25 basis point cuts that neither reignite inflation nor cause panic," he said.. He said the company could present new drugs, and he'll be focused on its up-and-coming obesity drug. The treatment is meant to help patients lose weight without losing muscle, an issue that can occur when using similar medicines.
Tuesday brings retail sales figures for August from the Commerce Department, which Cramer labeled as the last piece of significant data before the Fed's decision. He said the report is a good metric for consumer spending, and he predicted weak numbers.. Cramer said the packaged food company is trying to upgrade its portfolio, nothing that it sold its North American yogurt business, but that its remaining pet food and snack franchises remain solid.